Ursula Egner

Title: The Innovations of Ursula Egner

Introduction

Ursula Egner is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of biomedical research, particularly in the development of optimized humanized monoclonal antibodies. Her work focuses on innovative solutions that target specific proteins involved in critical biological processes.

Latest Patents

Ursula Egner holds a patent for an invention titled "Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof." This patent describes optimized humanized antibodies that selectively bind to and inhibit activated protein C without affecting unactivated protein C. The antibodies target specific epitopes outside the catalytic triad of the active site of human activated protein C. The methods of treatment employing these antibodies are also detailed in her patent.

Career Highlights

Ursula is affiliated with the Oklahoma Medical Research Foundation, where she continues her research and development efforts. Her work has garnered attention for its potential applications in therapeutic treatments, showcasing her commitment to advancing medical science.

Collaborations

Ursula has collaborated with notable colleagues, including Xinquan Wang and Lars Linden. These partnerships have contributed to the success of her research initiatives and the development of her patented technologies.

Conclusion

Ursula Egner's innovative work in the field of monoclonal antibodies exemplifies her dedication to improving medical treatments. Her contributions are paving the way for future advancements in biomedical research.